相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis
Marie-Claude Babron et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2012)
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP)
Nathali Kaushansky et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Implication of the Toll-Like Receptor 4 Pathway in the Response to Interferon-β in Multiple Sclerosis
Marta F. Bustamante et al.
ANNALS OF NEUROLOGY (2011)
Rare variants in the CYP27B1 gene are associated with multiple sclerosis
Sreeram V. Ramagopalan et al.
ANNALS OF NEUROLOGY (2011)
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci
Nikolaos A. Patsopoulos et al.
ANNALS OF NEUROLOGY (2011)
iCTNet: A Cytoscape plugin to produce and analyze integrative complex traits networks
Lili Wang et al.
BMC BIOINFORMATICS (2011)
Computational classifiers for predicting the short-term course of Multiple sclerosis
Bartolome Bejarano et al.
BMC NEUROLOGY (2011)
The major histocompatibility complex and multiple sclerosis: a smoking gun?
Stephen Sawcer et al.
BRAIN (2011)
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility
Nicolas Couturier et al.
BRAIN (2011)
Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis
Anna Karin Hedstrom et al.
BRAIN (2011)
Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis
J. E. Martinez-Rodriguez et al.
CLINICAL IMMUNOLOGY (2011)
Challenges in Obtaining Adequate Genetic Sample Sets in Clinical Trials: The Perspective of the Industry Pharmacogenomics Working Group
A. W. Warner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population
L. Romero-Pinel et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Genome-wide association study of severity in multiple sclerosis
Farren B. S. Briggs et al.
GENES AND IMMUNITY (2011)
Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex
Rebecca L. Zuvich et al.
HUMAN MOLECULAR GENETICS (2011)
The CD6 Multiple Sclerosis Susceptibility Allele Is Associated with Alterations in CD4+ T Cell Proliferation
David M. Kofler et al.
JOURNAL OF IMMUNOLOGY (2011)
Shared genetics in coeliac disease and other immune-mediated diseases
J. Gutierrez-Achury et al.
JOURNAL OF INTERNAL MEDICINE (2011)
Association of HLA class I markers with multiple sclerosis in the Italian and UK population: evidence of two independent protective effects
Laura Bergamaschi et al.
JOURNAL OF MEDICAL GENETICS (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
Predictive, personalized, preventive, participatory (P4) cancer medicine
Leroy Hood et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
The sociobiology of molecular systems
Kevin R. Foster
NATURE REVIEWS GENETICS (2011)
Network medicine: a network-based approach to human disease
Albert-Laszlo Barabasi et al.
NATURE REVIEWS GENETICS (2011)
Determinants of interferon β efficacy in patients with multiple sclerosis
Joep Killestein et al.
NATURE REVIEWS NEUROLOGY (2011)
Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse
Markus R. Meyer et al.
PHARMACOGENOMICS (2011)
Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
Qiang Ma et al.
PHARMACOLOGICAL REVIEWS (2011)
Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis
Haik Mkhikian et al.
NATURE COMMUNICATIONS (2011)
Pervasive Sharing of Genetic Effects in Autoimmune Disease
Chris Cotsapas et al.
PLOS GENETICS (2011)
Genome-wide Association Study in a High-Risk Isolate for Multiple Sclerosis Reveals Associated Variants in STAT3 Gene
Eveliina Jakkula et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Bayes factors in complex genetics
Stephen Sawcer
EUROPEAN JOURNAL OF HUMAN GENETICS (2010)
A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution
Sreeram V. Ramagopalan et al.
GENOME RESEARCH (2010)
Refining the association of MHC with multiple sclerosis in African Americans
Joseph P. McElroy et al.
HUMAN MOLECULAR GENETICS (2010)
Role of Differential Expression of Interferon Receptor Isoforms on the Response of Multiple Sclerosis Patients to Therapy with Interferon Beta
Francesca Gilli
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Two HLA class I genes independently associated with multiple sclerosis
Jenny Link et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis
Sandra Nischwitz et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis
Sergio E. Baranzini et al.
NATURE (2010)
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis
Serena Sanna et al.
NATURE GENETICS (2010)
A CD8+ T cell transcription signature predicts prognosis in autoimmune disease
Eoin F. McKinney et al.
NATURE MEDICINE (2010)
HLA B*44 Protective effects in MS susceptibility and MRI outcome
B. C. Healy et al.
NEUROLOGY (2010)
A Major Histocompatibility Class I Locus Contributes to Multiple Sclerosis Susceptibility Independently from HLA-DRB1*15:01
Bruce A. C. Cree et al.
PLOS ONE (2010)
Norwegian Sami differs significantly from other Norwegians according to their HLA profile
H. F. Harbo et al.
TISSUE ANTIGENS (2010)
Predictive, preventive, personalized and participatory medicine: back to the future
Charles Auffray et al.
GENOME MEDICINE (2010)
Killer Immunoglobulin-like Receptor Ligand HLA-Bw4 Protects Against Multiple Sclerosis
Aslaug R. Lorentzen et al.
ANNALS OF NEUROLOGY (2009)
Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA
Bruce A. C. Cree et al.
ARCHIVES OF NEUROLOGY (2009)
GenotypePhenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by (HMR)-H-1 spectroscopy and MRI measures
D. T. Okuda et al.
BRAIN (2009)
Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses
John P. A. Ioannidis
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Prediction of Cardiovascular Disease Outcomes and Established Cardiovascular Risk Factors by Genome-Wide Association Markers
John P. A. Ioannidis
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
The genetics of autoimmune diseases: a networked perspective
Sergio E. Baranzini
CURRENT OPINION IN IMMUNOLOGY (2009)
Identification of new sensitive biomarkers for the in vivo response to interferon-β treatment in multiple sclerosis using DNA-array evaluation
F. Sellebjerg et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
Sergio E. Baranzini et al.
HUMAN MOLECULAR GENETICS (2009)
HLA-DRB1*15 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis
Kerstin Imrell et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
Melanie Bahlo et al.
NATURE GENETICS (2009)
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
Philip L. De Jager et al.
NATURE GENETICS (2009)
OPINION A network view of disease and compound screening
Eric E. Schadt et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Detecting shared pathogenesis from the shared genetics of immune-related diseases
Alexandra Zhernakova et al.
NATURE REVIEWS GENETICS (2009)
Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility
Matthew R. Lincoln et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
IL2RA Genetic Heterogeneity in Multiple Sclerosis and Type 1 Diabetes Susceptibility and Soluble Interleukin-2 Receptor Production
Lisa M. Maier et al.
PLOS GENETICS (2009)
Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D
Sreeram V. Ramagopalan et al.
PLOS GENETICS (2009)
Protein networks in disease
Trey Ideker et al.
GENOME RESEARCH (2008)
Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis
Stacy J. Caillier et al.
JOURNAL OF IMMUNOLOGY (2008)
Gene expression analysis of interferon-β treatment in multiple sclerosis
F. Sellebjerg et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Interferon-beta responders and non-responders. A biological approach
Antonio Bertolotto et al.
NEUROLOGICAL SCIENCES (2008)
Pharmacogenomics of Interferon-β Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients
Lisa G. M. van Baarsen et al.
PLOS ONE (2008)
Identification of a Novel Risk Locus for Multiple Sclerosis at 13q31.3 by a Pooled Genome-Wide Scan of 500,000 Single Nucleotide Polymorphisms
Manuel Comabella et al.
PLOS ONE (2008)
Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event
Jean-Christophe Corvol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
N-glycan processing deficiency promotes spontaneous inflammatory demyelination and neurodegeneration
Sung-Uk Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
Melanie Newport et al.
NATURE GENETICS (2007)
Variation in interleukin 7 receptor a chain (IL7R) influences risk of multiple sclerosis
Frida Lundmark et al.
NATURE GENETICS (2007)
Interleukin 7 receptor a chain (IL7R) shows allelic and functional association with multiple sclerosis
Simon G. Gregory et al.
NATURE GENETICS (2007)
Risk alleles for multiple sclerosis identified by a genomewide study
David A. Hafler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The impact of HLA-A and-DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients
C. Smestad et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis
Boel Brynedal et al.
PLOS ONE (2007)
Moving toward a system genetics view of disease
Solveig K. Sieberts et al.
MAMMALIAN GENOME (2007)
Smoking is a risk factor for multiple sclerosis: a metanalysis
C. H. Hawkes
MULTIPLE SCLEROSIS JOURNAL (2007)
The human disease network
Kwang-Il Goh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami
H. F. Harbo et al.
TISSUE ANTIGENS (2007)
Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification
Paul A. Lyons et al.
BMC GENOMICS (2007)
A second major histocompatibility complex susceptibility locus for multiple sclerosis
Tai Wai Yeo et al.
ANNALS OF NEUROLOGY (2007)
Systems-based medicine approaches to understand and treat complex diseases. The example of multiple sclerosis
Sergio E. Baranzini
AUTOIMMUNITY (2006)
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis
Lisa F. Barcellos et al.
HUMAN MOLECULAR GENETICS (2006)
Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis
B Bielekova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The HLA locus and multiple sclerosis in Sicily
D Brassat et al.
NEUROLOGY (2005)
Genetics of autoimmune myasthenia gravis: The multifaceted contribution of the HLA complex
C Vandiedonck et al.
JOURNAL OF AUTOIMMUNITY (2005)
Transcription-based prediction of response to IFN beta using supervised computational methods
SE Baranzini et al.
PLOS BIOLOGY (2005)
Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis
HF Harbo et al.
TISSUE ANTIGENS (2004)
Network biology:: Understanding the cell's functional organization
AL Barabási et al.
NATURE REVIEWS GENETICS (2004)
Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies
A Bertolotto et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Smoking is a risk factor for multiple sclerosis
I Biran et al.
NEUROLOGY (2004)
Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans
JR Oksenberg et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Decreased integrin gene expression in patients with MS responding to interferon-β treatment
PA Muraro et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Smoking is a risk factor for multiple sclerosis
T Riise et al.
NEUROLOGY (2003)
TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis
KP Wandinger et al.
LANCET (2003)
Expression profiling identifies responder and non-responder phenotypes to interferon-β in multiple sclerosis
S Stürzebecher et al.
BRAIN (2003)
Microarray analysis identifies interferon β-regulated genes in multiple sclerosis
F Koike et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease
KE Lohmueller et al.
NATURE GENETICS (2003)
Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis
JP Rubio et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis
AE Hensiek et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia
MG Marrosu et al.
HUMAN MOLECULAR GENETICS (2001)
Complex immunomodulatory effects of interferon-β in multiple sclerosis include the upregulation of T helper 1-associated marker genes
KP Wandinger et al.
ANNALS OF NEUROLOGY (2001)
On the allelic spectrum of human disease
DE Reich et al.
TRENDS IN GENETICS (2001)
A genome screen for multiple sclerosis in Sardinian multiplex families
F Coraddu et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2001)
Cigarette smoking and incidence of multiple sclerosis
MA Hernán et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2001)
Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis
EG Celius et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2000)
Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease
A Fogdell-Hahn et al.
TISSUE ANTIGENS (2000)
分享论文
